Outer Membrane Vesicles Displaying a Heterologous PcrV-HitA Fusion Antigen Promote Protection against Pulmonary Pseudomonas aeruginosa Infection
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Outer Membrane Vesicles Displaying a Heterologous PcrV-HitA Fusion Antigen Promote Protection against Pulmonary Pseudomonas aeruginosa Infection
Authors
Keywords
-
Journal
mSphere
Volume 6, Issue 5, Pages -
Publisher
American Society for Microbiology
Online
2021-10-07
DOI
10.1128/msphere.00699-21
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recombinant Pseudomonas bio-nanoparticles induce protection against pneumonic Pseudomonas aeruginosa infection
- (2021) Peng Li et al. INFECTION AND IMMUNITY
- Induction of protective anti-plague immune responses by self-adjuvanting bionanoparticles derived from the engineered Yersinia pestis
- (2020) Xiuran Wang et al. INFECTION AND IMMUNITY
- Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes
- (2020) Rajendra Karki et al. CELL
- Defining the Mechanistic Correlates of Protection Conferred by Whole-Cell Vaccination against Pseudomonas aeruginosa Acute Murine Pneumonia
- (2020) Emel Sen-Kilic et al. INFECTION AND IMMUNITY
- Development of a Broadly Protective, Self-Adjuvanting Subunit Vaccine to Prevent Infections by Pseudomonas aeruginosa
- (2020) Sayan Das et al. Frontiers in Immunology
- The Iron Tug-of-War between Bacterial Siderophores and Innate Immunity
- (2019) Rachel Golonka et al. Journal of Innate Immunity
- Multidrug-resistant Pseudomonas aeruginosa and mortality inmechanically ventilated ICU patients
- (2019) Jean-Baptiste Denis et al. AMERICAN JOURNAL OF INFECTION CONTROL
- Use of bioengineered human commensal gut bacteria‐derived microvesicles for mucosal plague vaccine delivery and immunization
- (2019) A. L. Carvalho et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Immunization with the ferric iron-binding periplasmic protein HitA provides protection against Pseudomonas aeruginosa in the murine infection model
- (2019) Mona A. Elhosary et al. MICROBIAL PATHOGENESIS
- Rational Design of a Chimeric Derivative of PcrV as a Subunit Vaccine Against Pseudomonas aeruginosa
- (2019) Chuang Wan et al. Frontiers in Immunology
- Phosphatidylcholine biosynthesis in Mitis group streptococci via host metabolite scavenging
- (2019) Luke R. Joyce et al. JOURNAL OF BACTERIOLOGY
- Outer Membrane Vesicles: Current Status and Future Direction of These Novel Vaccine Adjuvants
- (2018) Kuang Tan et al. Frontiers in Microbiology
- Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies
- (2018) Zheng Pang et al. BIOTECHNOLOGY ADVANCES
- Progress Toward the Elusive Pseudomonas aeruginosa Vaccine
- (2018) Christina Merakou et al. Surgical Infections
- Protective Efficacy of the Trivalent Pseudomonas aeruginosa Vaccine Candidate PcrV-OprI-Hcp1 in Murine Pneumonia and Burn Models
- (2017) Feng Yang et al. Scientific Reports
- Outer membrane vesicles from flagellin-deficient Salmonella enterica serovar Typhimurium induce cross-reactive immunity and provide cross-protection against heterologous Salmonella challenge
- (2016) Qiong Liu et al. Scientific Reports
- A murine model of early Pseudomonas aeruginosa lung disease with transition to chronic infection
- (2016) H. K. Bayes et al. Scientific Reports
- Outer membrane vesicles as platform vaccine technology
- (2015) Leo van der Pol et al. Biotechnology Journal
- Outer membrane vesicles as platform vaccine technology
- (2015) Leo van der Pol et al. Biotechnology Journal
- Correlates of Protection for M Protein-Based Vaccines against Group A Streptococcus
- (2015) Shu Ki Tsoi et al. Journal of Immunology Research
- Vaccines forPseudomonas aeruginosa: a long and winding road
- (2014) Gregory P Priebe et al. Expert Review of Vaccines
- Lipopolysaccharide Engineering inNeisseria meningitidis
- (2014) Elder Pupo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- IL-17 Is a Critical Component of Vaccine-Induced Protection against Lung Infection by Lipopolysaccharide-Heterologous Strains of Pseudomonas aeruginosa
- (2014) G. P. Priebe et al. JOURNAL OF IMMUNOLOGY
- T Helper Cell Subsets Specific for Pseudomonas aeruginosa in Healthy Individuals and Patients with Cystic Fibrosis
- (2014) Hannah K. Bayes et al. PLoS One
- Anti-PcrV antibody strategies against virulent Pseudomonas aeruginosa
- (2014) Teiji Sawa et al. Human Vaccines & Immunotherapeutics
- Vaccination against respiratoryPseudomonas aeruginosainfection
- (2014) Keith Grimwood et al. Human Vaccines & Immunotherapeutics
- Mast cell and macrophage chemokines CXCL1/CXCL2 control the early stage of neutrophil recruitment during tissue inflammation
- (2013) K. De Filippo et al. BLOOD
- Prevalence, Risk Factors, and Mortality for Ventilator-Associated Pneumonia in Middle-Aged, Old, and Very Old Critically Ill Patients*
- (2013) Stijn Blot et al. CRITICAL CARE MEDICINE
- Pathogenicity of Yersinia pestis Synthesis of 1-Dephosphorylated Lipid A
- (2013) Wei Sun et al. INFECTION AND IMMUNITY
- In the Absence of Effector Proteins, the Pseudomonas aeruginosa Type Three Secretion System Needle Tip Complex Contributes to Lung Injury and Systemic Inflammatory Responses
- (2013) Jonathon P. Audia et al. PLoS One
- SuhB Is a Regulator of Multiple Virulence Genes and Essential for Pathogenesis of Pseudomonas aeruginosa
- (2013) K. Li et al. mBio
- Th17-stimulating Protein Vaccines Confer Protection againstPseudomonas aeruginosaPneumonia
- (2012) Weihui Wu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Safety and pharmacokinetics of an anti-PcrV PEGylated monoclonal antibody fragment in mechanically ventilated patients colonized with Pseudomonas aeruginosa
- (2012) Bruno François et al. CRITICAL CARE MEDICINE
- Amino acid substitutions in LcrV at putative sites of interaction with toll-like receptor 2 do not affect the virulence of Yersinia pestis
- (2012) Wei Sun et al. MICROBIAL PATHOGENESIS
- Discovery of a cardiolipin synthase utilizing phosphatidylethanolamine and phosphatidylglycerol as substrates
- (2012) B. K. Tan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pseudomonas aeruginosa: So many virulence factors, so little time*
- (2011) Alan R. Hauser CRITICAL CARE MEDICINE
- Understand memory, design better vaccines
- (2011) Michael J Bevan NATURE IMMUNOLOGY
- Multi-Functional Characteristics of the Pseudomonas aeruginosa Type III Needle-Tip Protein, PcrV; Comparison to Orthologs in other Gram-negative Bacteria
- (2011) Hiromi Sato et al. Frontiers in Microbiology
- Multiplex cytokine profiling in patients with sepsis
- (2010) SIMONA MERA et al. APMIS
- The Changing Microbial Epidemiology in Cystic Fibrosis
- (2010) J. J. LiPuma CLINICAL MICROBIOLOGY REVIEWS
- Early production of IL-17 protects against acute pulmonaryPseudomonas aeruginosainfection in mice
- (2010) Jialin Liu et al. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
- Mucosal Vaccination with a Multivalent, Live-Attenuated Vaccine Induces Multifactorial Immunity againstPseudomonas aeruginosaAcute Lung Infection
- (2010) Akinobu Kamei et al. INFECTION AND IMMUNITY
- Comparison of a Regulated Delayed Antigen Synthesis System withIn Vivo-Inducible Promoters for Antigen Delivery by Live AttenuatedSalmonellaVaccines
- (2010) Shifeng Wang et al. INFECTION AND IMMUNITY
- Delivery of foreign antigens by engineered outer membrane vesicle vaccines
- (2010) D. J. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- IgM in microbial infections: Taken for granted?
- (2009) Rachael Racine et al. IMMUNOLOGY LETTERS
- Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis
- (2009) Johan Holst et al. VACCINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started